BRABEVACNOR1
BRABEVACNOR1
AMBEV S/A ON
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 85/100, minimal insolvency risk). The high overall score (6/7) is driven primarily by extreme stock price swings (±23.6% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
6/7 High
6 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.2x).
Beta (Market Relation)
0.22x
DefensiveVolatility (5Y p.a.)
23.6% p.a.
5-Year HorizonMax Drawdown (5Y)
-39.5%
5-Year HorizonSharpe Ratio
-0.07
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +36.4% |
| 3 Years | 23.4% | -26.4% | 0.17 | +6.5% |
| 5 Years | 23.6% | -39.5% | -0.07 | +0.8% |
| 10 Years | 26.9% | -55.4% | -0.17 | -2.1% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Historical Stress Test: Maximum peak-to-trough drawdown of -55.4% in the extended horizon.